Durham-based Spyryx raises $5.9 million from seven investors
Biotechnology company Spyryx Biosciences has raised $5.9 million to fund its working capital and compensate its executive officers.
Read MorePosted by WRAL TechWire | Oct 5, 2018
Biotechnology company Spyryx Biosciences has raised $5.9 million to fund its working capital and compensate its executive officers.
Read MorePosted by WRAL News | Feb 16, 2018
Priay Kishnani, M.D., Chief of the Division of Medical Genetics, Department of Pediatrics and Director of the YT and Alice Chen Center for Genomic Research at Duke Health, will open the CED Life Science Conference February 27. The CED also set its agenda for the event. Pre-conference sessions from 9 a.m. to 10 a.m. features eight of the most promising life science startups from Duke, North Carolina State University, Wake Forest, and the University of North Carolina at Chapel Hill. The startups are: 410 Medical, Agile Sciences, AnelleO, EncepHeal Therapeutics, Phitonex, Spyryx, Zephyr Mobility, and Chondrial Therapeutics Inc. An Investors reverse...
Read More